These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7172405)

  • 1. The effect of timing of a single injection on the toxicity of methotrexate in the rat.
    English J; Aherne GW; Marks V
    Cancer Chemother Pharmacol; 1982; 9(2):114-7. PubMed ID: 7172405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of abolition of the endogenous corticosteroid rhythm on the circadian variation in methotrexate toxicity in the rat.
    English J; Aherne GW; Arendt J; Marks V
    Cancer Chemother Pharmacol; 1987; 19(4):287-90. PubMed ID: 3594715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronotoxicity and chronopharmacokinetics of methotrexate in mice: modification by feeding schedule.
    Song JG; Nakano S; Ohdo S; Ogawa N
    Jpn J Pharmacol; 1993 Aug; 62(4):373-8. PubMed ID: 8230864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronotoxicity of methotrexate in mice after intraperitoneal administration.
    Labat C; Mansour K; Malmary MF; Terrissol M; Oustrin J
    Chronobiologia; 1987; 14(3):267-75. PubMed ID: 3677924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian-time dependent tolerance and haematological toxicity to isoniazid in murine.
    Souayed N; Chennoufi M; Boughattas F; Hassine M; Ben Attia M; Aouam K; Reinberg A; Boughattas NA
    Biomed Pharmacother; 2015 Apr; 71():233-9. PubMed ID: 25960242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of peroral charcoal on pharmacokinetics and intestinal toxicity of intravenously given methotrexate.
    Scheufler E; Bos I
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):180-5. PubMed ID: 6838279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of kidney and liver subacute toxicity of antitumor agents using serum biochemical parameters in rats.
    Pispirigos K; Catsoulakos P; Karakiulakis G
    Biochem Mol Biol Int; 1993 Nov; 31(3):565-73. PubMed ID: 7906982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate in psoriasis with and without leucovorin: effect of different dosage schedules on acute liver toxicity.
    Zachariae H; Bjerring P
    Acta Derm Venereol; 1982; 62(5):446-8. PubMed ID: 6183902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral methotrexate in psoriasis. A report on the efficacy and toxicity of long-term intermittent treatment.
    McDonald CJ; Bertino JR
    Arch Dermatol; 1969 Dec; 100(6):655-68. PubMed ID: 4243752
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion pattern.
    Goldie JH; Price LA; Harrap KR
    Eur J Cancer (1965); 1972 Aug; 8(4):409-14. PubMed ID: 5073303
    [No Abstract]   [Full Text] [Related]  

  • 11. Circadian effect on carbamazepine kinetics in rat.
    Bruguerolle B; Valli M; Bouyard L; Jadot G; Bouyard P
    Eur J Drug Metab Pharmacokinet; 1981; 6(3):189-93. PubMed ID: 7030746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of gallic acid against methotrexate-induced toxicity in rats.
    Safaei F; Mehrzadi S; Khadem Haghighian H; Hosseinzadeh A; Nesari A; Dolatshahi M; Esmaeilizadeh M; Goudarzi M
    Acta Chir Belg; 2018 Jun; 118(3):152-160. PubMed ID: 29069994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximum tolerated doses of methotrexate and 7-hydroxy-methotrexate in a model of acute toxicity in rats.
    Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
    Cancer Chemother Pharmacol; 2000; 46(1):69-73. PubMed ID: 10912581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats.
    Mehrzadi S; Fatemi I; Esmaeilizadeh M; Ghaznavi H; Kalantar H; Goudarzi M
    Biomed Pharmacother; 2018 Jan; 97():233-239. PubMed ID: 29091871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential laboratory determinations for monitoring high-dose methotrexate treatment with citrovorum factor rescue.
    Jürgens H; Ebell W; Bachmann R; Kupke I; Richter O; Andräs A; Göbel U
    Pediatr Pharmacol (New York); 1983; 3(3-4):157-65. PubMed ID: 6610851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity.
    Stoller RG; Hande KR; Jacobs SA; Rosenberg SA; Chabner BA
    N Engl J Med; 1977 Sep; 297(12):630-4. PubMed ID: 302412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Seasonal and circadian fluctuations of the biochemical indices of the blood in mice].
    Berezkin MV; Gratsinskiĭ IuN; Kudinova VF; Chusovkova TS
    Biull Eksp Biol Med; 1987 Dec; 104(12):646-9. PubMed ID: 3689950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variation of isoniazid pharmacokinetics in mice.
    Souayed N; Chennoufi M; Frej NB; Chaabane A; Ben-Attia M; Aouam K; Reinberg A; Boughattas NA
    Biomed Pharmacother; 2016 Dec; 84():1150-1155. PubMed ID: 27780145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.
    Bannwarth B; Péhourcq F; Schaeverbeke T; Dehais J
    Clin Pharmacokinet; 1996 Mar; 30(3):194-210. PubMed ID: 8882301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An animal model for the study of chronopharmacokinetics of drugs and application to methotrexate and vinorelbine.
    Prémaud A; Rousseau A; Gicquel M; Ragot S; Manceau J; Laurentie M; Marquet P
    Toxicol Appl Pharmacol; 2002 Sep; 183(3):189-97. PubMed ID: 12383710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.